Trials / Terminated
TerminatedNCT02624661
Glycerol Block of the Trigeminal Ganglion in Trigeminal Neuralgia Using a New Neuronavigation-based Surgical Technique
- Status
- Terminated
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Norwegian University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Trigeminal neuralgia is one of the strongest pains known to humans. Some patients do not have enough effect with the available pharmaceutical treatments and are offered a type of surgery, which involves the injection of glycerol in a nerve structure called trigeminal ganglion. The researchers will do a pilot study on 10 patients with a new surgical technique using neuronavigation. The researchers believe that this new neuronavigation-based system can improve the precision of the technique and reduce the risk for complications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glycerol |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2019-01-01
- Completion
- 2019-01-01
- First posted
- 2015-12-08
- Last updated
- 2019-03-27
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT02624661. Inclusion in this directory is not an endorsement.